Lawrence Corey

101.2k total citations · 16 hit papers
840 papers, 63.4k citations indexed

About

Lawrence Corey is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Lawrence Corey has authored 840 papers receiving a total of 63.4k indexed citations (citations by other indexed papers that have themselves been cited), including 609 papers in Epidemiology, 289 papers in Infectious Diseases and 239 papers in Virology. Recurrent topics in Lawrence Corey's work include Herpesvirus Infections and Treatments (410 papers), Cytomegalovirus and herpesvirus research (285 papers) and HIV Research and Treatment (198 papers). Lawrence Corey is often cited by papers focused on Herpesvirus Infections and Treatments (410 papers), Cytomegalovirus and herpesvirus research (285 papers) and HIV Research and Treatment (198 papers). Lawrence Corey collaborates with scholars based in United States, South Africa and Canada. Lawrence Corey's co-authors include Anna Wald, Michael Boeckh, David M. Koelle, Stacy Selke, Meei‐Li Huang, Rhoda L. Ashley, Jacqueline Benedetti, Kieren A. Marr, Robert W. Coombs and M. Juliana McElrath and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Lawrence Corey

831 papers receiving 60.8k citations

Hit Papers

Efficacy assessment of a cell-media... 1983 2026 1997 2011 2008 2002 1990 2002 1983 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
    2008 1.2k citations Susan Buchbinder, Devan V. Mehrotra et al. profile →
  2. Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
    2002 1.1k citations Anna Wald, Lawrence Corey et al. Clinical Infectious Diseases profile →
  3. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
    1990 951 citations Lawrence Corey et al. profile →
  4. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
    2002 726 citations Michael Boeckh, Lawrence Corey et al. profile →
  5. Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
    1983 663 citations Lawrence Corey et al. profile →
  6. Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
    1993 660 citations David R. Gretch, Lawrence Corey et al. profile →
  7. Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection
    1998 642 citations Lawrence Corey et al. profile →
  8. Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
    1996 600 citations Ann C. Collier, Robert W. Coombs et al. profile →
  9. Infections with Herpes Simplex Viruses
    1986 568 citations Lawrence Corey et al. profile →
  10. The Acquisition of Herpes Simplex Virus during Pregnancy
    1997 543 citations Lawrence Corey et al. profile →
  11. Vaccine Prevention of Maternal Cytomegalovirus Infection
    2009 527 citations Meei‐Li Huang, Lawrence Corey et al. profile →
  12. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
    2008 517 citations M. Juliana McElrath, Sheri Dubey et al. profile →
  13. Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal Cancer
    1987 488 citations Lawrence Corey et al. profile →
  14. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
    1988 462 citations Lawrence Corey et al. profile →
  15. SARS-CoV-2 Variants in Patients with Immunosuppression
    2021 263 citations Lawrence Corey et al. profile →
  16. After the pandemic: perspectives on the future trajectory of COVID-19
    2021 255 citations Lawrence Corey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Corey United States 131 41.4k 22.1k 15.7k 11.7k 8.7k 840 63.4k
Albert D. M. E. Osterhaus Netherlands 118 40.9k 1.0× 34.5k 1.6× 5.4k 0.3× 13.8k 1.2× 2.3k 0.3× 1.0k 74.2k
Anthony S. Fauci United States 158 20.3k 0.5× 25.0k 1.1× 32.9k 2.1× 34.9k 3.0× 5.9k 0.7× 796 95.6k
Alessandro Sette United States 142 14.2k 0.3× 17.2k 0.8× 8.1k 0.5× 40.0k 3.4× 6.8k 0.8× 858 72.2k
Rafi Ahmed United States 137 15.0k 0.4× 10.0k 0.5× 6.1k 0.4× 55.3k 4.7× 17.4k 2.0× 469 76.0k
Robert C. Gallo United States 128 13.3k 0.3× 18.5k 0.8× 29.3k 1.9× 35.1k 3.0× 10.7k 1.2× 700 76.9k
Bruce D. Walker United States 120 13.0k 0.3× 15.3k 0.7× 32.6k 2.1× 27.6k 2.4× 2.5k 0.3× 583 52.4k
Daniel C. Douek United States 104 9.5k 0.2× 11.1k 0.5× 19.1k 1.2× 26.6k 2.3× 6.1k 0.7× 338 44.9k
Richard A. Koup United States 102 9.4k 0.2× 13.9k 0.6× 22.9k 1.5× 24.4k 2.1× 4.0k 0.5× 309 42.6k
Andrew J. McMichael United Kingdom 109 11.9k 0.3× 8.4k 0.4× 15.0k 1.0× 33.7k 2.9× 4.7k 0.5× 471 49.5k
Thomas C. Quinn United States 98 17.1k 0.4× 21.5k 1.0× 17.5k 1.1× 6.0k 0.5× 687 0.1× 681 43.8k

Countries citing papers authored by Lawrence Corey

Since Specialization
Citations

This map shows the geographic impact of Lawrence Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Corey more than expected).

Fields of papers citing papers by Lawrence Corey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Corey. The network helps show where Lawrence Corey may publish in the future.

Co-authorship network of co-authors of Lawrence Corey

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Corey. A scholar is included among the top collaborators of Lawrence Corey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Corey. Lawrence Corey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oo, Myo Minn, Katherine K. Thomas, Connie Celum, et al.. (2024). Pre–Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in Africa. The Journal of Infectious Diseases. 231(4). e770–e780. 1 indexed citations
2.
Cieniewicz, Brandon, Edson Oliveira, Phanidhar Kukutla, et al.. (2024). Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia. Clinical Cancer Research. 30(9). 1878–1888.
3.
4.
Ford, Emily S., Anton M. Sholukh, Alexis Klock, et al.. (2021). B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin. Journal of Clinical Investigation. 131(9). 15 indexed citations
5.
Lin, Dan-Yu, Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, & Peter B. Gilbert. (2020). Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines. Clinical Infectious Diseases. 73(8). 1540–1544. 11 indexed citations
6.
Huang, Ying, Carlos A. DiazGranados, Holly Janes, et al.. (2016). Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17. 57–65. 7 indexed citations
7.
Kuypers, Jane, Angela P. Campbell, Katherine A. Guthrie, et al.. (2012). WU and KI Polyomaviruses in Respiratory Samples from Allogeneic Hematopoietic Cell Transplant Recipients. Emerging infectious diseases. 18(10). 1580–1588. 30 indexed citations
8.
Gantt, Soren, Matthew D. Gray, Adam P. Geballe, et al.. (2011). The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro. Antimicrobial Agents and Chemotherapy. 55(6). 2696–2703. 60 indexed citations
9.
Li, Fusheng, Adam C. Finnefrock, Sheri Dubey, et al.. (2011). Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study. PLoS ONE. 6(6). e20479–e20479. 56 indexed citations
10.
Scott, John D., Anna Wald, Mari M. Kitahata, et al.. (2009). Hepatitis C Virus Is Infrequently Evaluated and Treated in an Urban HIV Clinic Population. AIDS Patient Care and STDs. 23(11). 925–929. 23 indexed citations
11.
12.
Peng, Tao, Jia Zhu, Alexis Klock, et al.. (2009). Evasion of the Mucosal Innate Immune System by Herpes Simplex Virus Type 2. Journal of Virology. 83(23). 12559–12568. 50 indexed citations
13.
Kuypers, Jane, Angela P. Campbell, Anne Cent, Lawrence Corey, & Michael Boeckh. (2009). Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transplant Infectious Disease. 11(4). 298–303. 92 indexed citations
14.
Corey, Lawrence, et al.. (2007). An update on short-course intermittent and prevention therapies for herpes labialis.. PubMed. 14 Suppl 1. 13A–18A. 14 indexed citations
15.
Sullivan, Daniel G., et al.. (2003). Salivary shedding of HCV is associated with serum HCV RNA level and the presence of periodontal disease. 43. 494. 2 indexed citations
16.
Wald, Anna, P. L. Matson, Alexander J. Ryncarz, & Lawrence Corey. (1999). Detection of Herpes Simplex Virus DNA in Semen of Men With Genital HSV-2 Infection. Sexually Transmitted Diseases. 26(1). 1–3. 31 indexed citations
17.
Kent, Stephen J., Virginia Stallard, Lawrence Corey, et al.. (1994). Analysis of Cytotoxic T Lymphocyte Responses to SIV Proteins in SIV-Infected Macaques Using Antigen-Specific Stimulation with Recombinant Vaccinia and Fowl Poxviruses. AIDS Research and Human Retroviruses. 10(5). 551–560. 9 indexed citations
18.
Hoffman, Mark A., et al.. (1994). HIV-Infected Macrophages as Efficient Stimulator Cells for Detection of Cytotoxic T Cell Responses to HIV in Seronegative and Seropositive Vaccine Recipients. AIDS Research and Human Retroviruses. 10(5). 541–549. 12 indexed citations
19.
Keefer, Michael C., Barney S. Graham, Robert B. Belshe, et al.. (1994). Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans. AIDS Research and Human Retroviruses. 10(12). 1713–1723. 46 indexed citations
20.
Agosti, Jan M., Robert W. Coombs, Ann C. Collier, et al.. (1992). A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group). AIDS Research and Human Retroviruses. 8(5). 581–587. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albert D. M. E. Osterhaus Breakdown of academic impact, for papers by Anthony S. Fauci Breakdown of academic impact, for papers by Alessandro Sette Breakdown of academic impact, for papers by Rafi Ahmed Breakdown of academic impact, for papers by Robert C. Gallo Breakdown of academic impact, for papers by Bruce D. Walker Breakdown of academic impact, for papers by Daniel C. Douek Breakdown of academic impact, for papers by Richard A. Koup Breakdown of academic impact, for papers by Andrew J. McMichael Breakdown of academic impact, for papers by Thomas C. Quinn
Rankless by CCL
2026